Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...

UM researchers have developed a deep learning model to predict compound protein interactions. GraphBAN is an inductive ...

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating ...

AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Johnson & Johnson, while primarily known as America's leading healthcare company, now employs nearly 7,000 digital specialists and data scientists.

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...